| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TIPS.2008.08.005 |
| P698 | PubMed publication ID | 18835046 |
| P2093 | author name string | Rebecca H Ritchie | |
| Jennifer C Irvine | |||
| Karen L Andrews | |||
| Barbara K Kemp-Harper | |||
| Joanne L Favaloro | |||
| Robert E Widdop | |||
| P433 | issue | 12 | |
| P304 | page(s) | 601-608 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | Nitroxyl (HNO): the Cinderella of the nitric oxide story | |
| P478 | volume | 29 |
| Q51647897 | A FRET-based ratiometric two-photon fluorescent probe for dual-channel imaging of nitroxyl in living cells and tissues. |
| Q64927542 | A Mononuclear, Nonheme FeII-Piloty's Acid (PhSO2NHOH) Adduct: An Intermediate in the Production of {FeNO}7/8 Complexes from Piloty's Acid. |
| Q38693298 | A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. |
| Q26824749 | A critical review of pharmacological significance of Hydrogen Sulfide in hypertension |
| Q39000913 | A fast-response, highly sensitive and selective fluorescent probe for the ratiometric imaging of nitroxyl in living cells |
| Q46725818 | A near-infrared fluorescent probe for the selective detection of HNO in living cells and in vivo |
| Q42116696 | A novel role for HNO in local and spreading vasodilatation in rat mesenteric resistance arteries. |
| Q88956991 | A recent history of nitroxyl chemistry, pharmacology and therapeutic potential |
| Q37255292 | A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. |
| Q41839668 | A selective phosphine-based fluorescent probe for nitroxyl in living cells |
| Q27002433 | A tale of two gases: NO and H2S, foes or friends for life? |
| Q58205578 | A thermally stable {FeNO}8complex: properties and biological reactivity of reduced MNO systems |
| Q34586679 | Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties |
| Q38959942 | Agents with vasodilator properties in acute heart failure |
| Q38613516 | Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta |
| Q41903293 | Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses |
| Q43239804 | Arylazoamidoximes and related compounds as NO-modulators. |
| Q37851240 | Cardiac inotropes: current agents and future directions |
| Q42720847 | Comparison of Reductive Ligation-Based Detection Strategies for Nitroxyl (HNO) and S-Nitrosothiols |
| Q36301582 | Design and Synthesis of Near-infrared Fluorescent Probes for Imaging of Biological Nitroxyl. |
| Q42681487 | Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C. |
| Q40434222 | Direct detection of nitroxyl in aqueous solution using a tripodal copper(II) BODIPY complex |
| Q38597441 | Discriminative EPR detection of NO and HNO by encapsulated nitronyl nitroxides. |
| Q37728969 | Endothelium-derived hyperpolarising factors and associated pathways: a synopsis |
| Q37438138 | Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase |
| Q52646346 | Evaluation of nitroxyl donors' effect on mycobacteria. |
| Q88955948 | Extension of C. elegans lifespan using the ·NO-delivery dinitrosyl iron complexes |
| Q43755565 | HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO. |
| Q42957349 | Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl |
| Q39234570 | Hydroxylamine acutely activates glucose uptake in L929 fibroblast cells |
| Q55039748 | Influences of the heme-lysine crosslink in cytochrome P460 over redox catalysis and nitric oxide sensitivity. |
| Q59726944 | Kinetic and Mechanistic Studies on the Reactions of the Reduced Vitamin B12 Complex Cob(I)alamin with Nitrite and Nitrate |
| Q50763935 | Mechanistic studies of the reactions of the reduced vitamin B12 derivatives with the HNO donor Piloty's acid: further evidence for oxidation of cob(I)alamin by (H)NO. |
| Q48047879 | Modeling of S-Nitrosothiol-Thiol Reactions of Biological Significance: HNO Production by S-Thiolation Requires a Proton Shuttle and Stabilization of Polar Intermediates |
| Q47669705 | NO and HNO donors, nitrones, and nitroxides: Past, present, and future |
| Q36011399 | New acyloxy nitroso compounds with improved water solubility and nitroxyl (HNO) release kinetics and inhibitors of platelet aggregation |
| Q51308937 | New dinitrosyl iron complexes bound with physiologically active dipeptide carnosine. |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q39425650 | Nitroxyl (HNO) acutely activates the glucose uptake activity of GLUT1. |
| Q34738088 | Nitroxyl (HNO) reacts with molecular oxygen and forms peroxynitrite at physiological pH. Biological Implications. |
| Q34233761 | Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation |
| Q26771830 | Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties |
| Q43097999 | Nitroxyl anion--the universal signalling partner of endogenously produced nitric oxide? |
| Q39995085 | Nitroxyl as a ligand in ruthenium tetraammine systems: a density functional theory study |
| Q37142767 | Nitroxyl donors retain their depressor effects in hypertension. |
| Q33925515 | Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway |
| Q41283236 | Nitroxyl, redox switches, cardiac myofilaments, and heart failure: a prequel to novel therapeutics? |
| Q49739561 | Nitroxyl, the novel redox sibling of NO, suppresses cerebrovascular NADPH oxidase. |
| Q46241410 | NitroxylFluor: A Thiol-Based Fluorescent Probe for Live-Cell Imaging of Nitroxyl. |
| Q26765793 | Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology |
| Q62390869 | O2-Functionalized Methylamine Diazeniumdiolates: Evidence for E ⇄ Z Equilibration in an Acyclic System |
| Q36573243 | Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects. |
| Q37233345 | Potential biological chemistry of hydrogen sulfide (H2S) with the nitrogen oxides |
| Q34160436 | Proton-induced reactivity of NO⁻ from a {CoNO}⁸ complex |
| Q39340228 | Ratiometric Fluorescent Probes for the Detection of Reactive Oxygen Species |
| Q34030551 | Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects. |
| Q37010822 | Recent advances in the chemical biology of nitroxyl (HNO) detection and generation |
| Q46104588 | Redox variants of NO (NO⋅ and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms |
| Q36351009 | Ring expansions of acyloxy nitroso compounds |
| Q58766337 | Role of Nitric Oxide in the Cardiovascular and Renal Systems |
| Q38227299 | Ruthenium complexes as NO donors for vascular relaxation induction |
| Q84524033 | S-nitrosothiol chemistry at the single-molecule level |
| Q37767680 | Sickle cell anemia and vascular dysfunction: the nitric oxide connection |
| Q28833738 | Signaling and stress: The redox landscape in NOS2 biology |
| Q38843402 | Stem cells and diabetic cardiomyopathy: from pathology to therapy |
| Q39037342 | Sulfonimidamides in Medicinal and Agricultural Chemistry |
| Q41877565 | Synthesis of Nitric Oxide Donors Derived from Piloty's Acid and Study of Their Effects on Dopamine Secretion from PC12 Cells |
| Q38935734 | The chemical biology of HNO signaling |
| Q35040403 | The chemistry of nitroxyl-releasing compounds |
| Q37665613 | The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. |
| Q37281633 | The effects of nitroxyl (HNO) on H₂O₂ metabolism and possible mechanisms of HNO signaling |
| Q33580106 | The nitric oxide-cGKII system relays death and survival signals during embryonic retinal development via AKT-induced CREB1 activation |
| Q36884713 | The nitroxyl donor, Angeli's salt, inhibits inflammatory hyperalgesia in rats |
| Q42365805 | The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain |
| Q93551245 | The novel NO redox sibling, nitroxyl (HNO), prevents cardiomyocyte hypertrophy and superoxide generation via cGMP |
| Q38827338 | Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure |
| Q37725077 | Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention |
| Q39722744 | Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia |
| Q38950500 | Visualization of nitroxyl (HNO) in vivo via a lysosome-targetable near-infrared fluorescent probe |
| Q42403629 | Water soluble acyloxy nitroso compounds: HNO release and reactions with heme and thiol containing proteins |
| Q37276166 | cGMP does not activate two-pore domain K+ channels in cerebrovascular smooth muscle |
Search more.